Gilead had added 45-day time limits for replenishment orders and claims submissions under its 340B contract pharmacy restrictions on Harvoni and its other branded hepatitis C medicines.

Gilead Adds 45-Day Lookback Clause to its 340B Contract Pharmacy Policy

Drug manufacturer Gilead on Wednesday added 45-day time limits for replenishment orders and claims submissions to its conditions on 340B pricing when covered entities use contract pharmacies.

Ten manufacturers require covered entities to provide claims data to industry contractor 340B ESP in exchange for being able to use more than one contract pharmacy to dispense the company’s drugs. Gilead is the seventh to incorporate a 45-day lookback clause in its policy. The others are Amgen, GlaxoSmithKline (GSK), Johnson & Johnson (J&J), Lilly, Pfizer, and Sanofi.

Drug manufacturer Gilead on Wednesday added 45-day time limits for replenishment orders and claims submissions to its conditions on 340B pricing when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer